Liver Disease in the Face of COVID-19

Elizabeth C. Verna, MD, MSc
Frank Cardile Associate Professor of Medicine, Columbia University Medical Center
Director of Clinical Research, Columbia University Transplant Initiative
and the Transplant Clinical Research Center, New York, NY

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2021. All rights reserved.



VIDEOTop of page

How to Obtain CME Credit:Top of page

About the Presenter:Top of page

Dr. Elizabeth Verna is the Frank Cardile Associate Professor of Medicine at Columbia University Irving Medical Center, where she practices as a transplant hepatologist. Dr. Verna has an active clinical research program in end-stage liver disease and liver transplantation and is the Director of Clinical Research for the Columbia University Transplant Clinical Research Center as well as the Director of Hepatology Research for the Division of Digestive and Liver Diseases.

Learning Objectives: Top of page

At the completion of this educational session, participants will:
1. Understand the impact of COVID-19-related liver injury upon patient outcomes.
2. Understand whether chronic liver disease increases the risk of severe COVID-19-related illness.
3. Understand how the COVID-19 pandemic has impacted the care of patients with chronic liver disease including the initiatives regarding viral hepatitis elimination.

CME Information:Top of page


This CME activity has approved for AMA PRA Category 1 Credit™ for June 23, 2021 as a live activity.  This activity will also be available as an enduring activity from June 24, 2021, through June 22, 2024.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.

- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.

- Dr. Elizabeth C. Verna (Presenter) has no relevant financial relationships to disclose. Dr. Verna will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Evaluation

You must be logged in to post a comment. Login | Register